Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Recursion Pharmaceuticals Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board May 24, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry May 13, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results May 09, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9 May 02, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion to Participate in Upcoming Investor Conferences May 01, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program April 30, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion to Participate in Upcoming Investor Conference April 02, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Publishes Annual Environmental, Social and Governance Report March 26, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community March 01, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion to Participate in Upcoming Investor Conferences March 01, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results February 27, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion to Host Public L(earnings) Call on February 27 February 20, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Altitude Lab Startups Raise Over $120M in Capital January 24, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference January 08, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8 January 03, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry December 20, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Bayer and Recursion Focus Research Collaboration on Oncology November 09, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results November 09, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion to Participate in Upcoming Investor Conference November 02, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion to Participate in Upcoming Investor Conferences September 05, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection September 05, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds August 08, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results August 08, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion to Participate in Upcoming Investor Conference August 01, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships July 26, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery July 12, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem June 26, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled June 13, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion to Participate in Upcoming Investor Conferences June 01, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer May 16, 2023 From Recursion Pharmaceuticals Via GlobeNewswire Tickers RXRX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.